SEC filing · 8-K

Decoy Therapeutics Inc.: Material agreement

Decoy Therapeutics raised approximately $3.85 million in gross proceeds through a warrant inducement transaction.

Filed September 23, 2026

Positive for the company

What happened

Decoy Therapeutics entered into an inducement agreement with an existing institutional investor to immediately exercise Series B milestone warrants for 1,184,434 shares of common stock.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Decoy Therapeutics Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.